David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Fresenius Medical Care
FMS
$12.5B
| $2.09M | ﹤0.01% |
+42,833
| New | +$2.04M |
|
1952
Priority Technology Holdings
PRTH
$470M
| $2.09M | ﹤0.01% |
205,000
| – | – |
|
|
ABCO
1953
DELISTED
Advisory Board Co
ABCO
| $2.09M | ﹤0.01% |
38,973
-128,930
| -77% | -$6.95M |
|
1954
Xencor
XNCR
$2.16B
| $2.09M | ﹤0.01% |
91,012
+38,141
| +72% | +$847K |
|
1955
Houlihan Lokey
HLI
$9.11B
| $2.08M | ﹤0.01% |
53,290
-34,089
| -39% | -$1.25M |
|
1956
Marten Transport
MRTN
$1.18B
| $2.08M | ﹤0.01% |
152,198
-5,825
| -4% | -$66.1K |
|
1957
Phunware
PHUN
$43M
| $2.08M | ﹤0.01% |
4,100
| – | – |
|
1958
Petrobras
PBR
$115B
| $2.08M | ﹤0.01% |
207,035
-248,538
| -55% | -$2.26M |
|
|
THR
1959
DELISTED
Thermon Group Holdings
THR
| $2.08M | ﹤0.01% |
115,571
-2,677
| -2% | -$46.9K |
|
1960
Ingredion
INGR
$6.62B
| $2.07M | ﹤0.01% |
17,189
-22,593
| -57% | -$2.75M |
|
|
ONC
1961
BeOne Medicines Ltd
ONC
$42.4B
| $2.07M | ﹤0.01% |
+20,039
| New | +$1.49M |
|
1962
CALL
Rogers Corp
ROG
$2.26B
| $2.07M | ﹤0.01% |
+15,500
| New | +$1.84M |
|
|
TAST
1963
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.07M | ﹤0.01% |
189,562
+74,850
| +65% | +$869K |
|
|
NE
1964
DELISTED
Noble Corporation
NE
| $2.07M | ﹤0.01% |
449,297
-1,354,998
| -75% | -$5.09M |
|
1965
PUT
New Oriental
EDU
$9.17B
| $2.06M | ﹤0.01% |
23,400
| – | – |
|
|
PARA
1966
DELISTED
Paramount Global Class B
PARA
| $2.06M | ﹤0.01% |
35,599
-56,829
| -61% | -$3.59M |
|
|
KTWO
1967
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.06M | ﹤0.01% |
+96,989
| New | +$2.25M |
|
1968
PUT
TripAdvisor
TRIP
$1.17B
| $2.06M | ﹤0.01% |
50,700
-6,700
| -12% | -$272K |
|
|
CTT
1969
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $2.04M | ﹤0.01% |
161,638
+14,503
| +10% | +$169K |
|
1970
PUT
ArcelorMittal
MT
$56.4B
| $2.04M | ﹤0.01% |
79,100
+53,200
| +205% | +$1.38M |
|
|
MRO
1971
CALL
DELISTED
Marathon Oil Corporation
MRO
| $2.04M | ﹤0.01% |
+150,300
| New | +$1.78M |
|
|
DBD
1972
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.03M | ﹤0.01% |
+89,009
| New | +$1.9M |
|
|
ARRY
1973
DELISTED
Array Biopharma Inc
ARRY
| $2.03M | ﹤0.01% |
+164,933
| New | +$1.53M |
|
1974
General Mills
GIS
$21.5B
| $2.02M | ﹤0.01% |
39,114
-739,872
| -95% | -$40.6M |
|
|
CUK
1975
DELISTED
Carnival PLC
CUK
| $2.02M | ﹤0.01% |
+31,396
| New | +$2.11M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.